Skip to content

Ethan H. Mcilhenny

Louisiana State University

4 papers in the library · 324 citations · publishing 2011-2014

Papers

Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca

Journal of Clinical Psychopharmacology October 15, 2011 Rafael G. Dos Santos, Marta Valle, José Carlos Bouso et al. 136 citations

Ayahuasca, an Amazonian psychotropic tea containing DMT and β-carboline alkaloids, produced moderate sympathomimetic effects, significant increases in prolactin and cortisol, and time-dependent changes in immune cell populations in a double-blind crossover trial with 10 healthy volunteers. Pupil dilation occurred with both ayahuasca and amphetamine, but ayahuasca’s effects were milder. Prolactin rose only after ayahuasca, while cortisol peaked higher with ayahuasca than with amphetamine. Lymphocyte subsets shifted similarly for both drugs: CD4 and CD3 percentages decreased, and natural killer cells increased, with maximum changes at 2 hours and return to baseline by 24 hours.

Metabolism and urinary disposition of N,N‐dimethyltryptamine after oral and smoked administration: a comparative study

Drug Testing and Analysis July 28, 2014 Jordi Riba, Ethan H. Mcilhenny, José Carlos Bouso et al. 96 citations

When N,N-dimethyltryptamine (DMT) is taken orally, it produces no psychedelic effects and no DMT appears in urine, because monoamine oxidase (MAO) breaks it down almost completely into indole-3-acetic acid (97% of recovered compounds). By contrast, smoking DMT yields full psychoactivity, with unmetabolized DMT and DMT-N-oxide rising to 10% and 28% of recovered compounds, while indole-3-acetic acid drops to 63%. An inverse relationship between the ratio of these metabolites and subjective effects indicates that smoking shifts metabolism from efficient MAO-dependent breakdown to less efficient CYP-dependent pathways, enabling psychoactivity.

Metabolism and disposition of N,N‐dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

Drug Testing and Analysis April 19, 2012 Jordi Riba, Ethan H. Mcilhenny, Marta Valle et al. 91 citations

Ayahuasca, an Amazonian tea containing β-carboline alkaloids (harmine, harmaline, tetrahydroharmine) and the psychedelic DMT, is used worldwide, but its metabolism in humans had not been systematically studied. In 10 healthy men given freeze-dried ayahuasca (1.0 mg DMT/kg), less than 1% of DMT was excreted unchanged; about 50% was recovered as indole-3-acetic acid, 10% as DMT-N-oxide, and total DMT plus metabolites reached 68%. Harmala alkaloids were excreted as O-demethylated and conjugated metabolites, but recoveries varied from 9% to 65%. The findings indicate alternative metabolic routes for DMT beyond monoamine-oxidase and that O-demethylation plus conjugation is important but not the only pathway for harmala alkaloids.

Ayahuasca characterization, metabolism in humans, and relevance to endogenous N,N-dimethyltryptamines

June 8, 2012 Ethan H. Mcilhenny, Ethan Mcilhenny 1 citation

Ayahuasca is an Amazonian tea made from Banisteriopsis caapi, which contains beta-carboline alkaloids (harmine, harmaline, tetrahydroharmine) that inhibit monoamine oxidase, and often Psychotria viridis leaves rich in DMT, a psychoactive 5-HT2A agonist. A new liquid chromatography-tandem mass spectrometry method was developed to quantify the major alkaloids and their metabolites in ayahuasca, human blood, and urine. The main components in the tea were tetrahydroharmine and harmine, followed by DMT and harmaline. DMT's major metabolite was DMT-N-oxide, found in blood and urine but not in the tea. Less than 1% of the DMT dose appeared in urine or blood, despite MAO inhibition. Tetrahydroharmine was the main harmala alkaloid excreted. The method is suitable for human, ethnobotanical, and forensic studies.